Rick E Winningham Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rick E Winningham.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rick E Winningham. Rick E Winningham is Chief Executive Officer in Innoviva, Inc. ($THRX) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of Rick E Winningham
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, THRX, JAZZ, OMED, TBPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 170,000 | 0 | 1,445,169 | 1.3 M to 1.4 M (+13.33 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 18.22 | 13,946 | 254,096 | 1,289,115 | 1.3 M to 1.3 M (-1.07 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 125.87 | 931 | 117,185 | 6,198 | 7.1 K to 6.2 K (-13.06 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 2,705 | 0 | 7,129 | 4.4 K to 7.1 K (+61.14 %) |
| May 22 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 26.67 | 13,946 | 371,940 | 1,303,061 | 1.3 M to 1.3 M (-1.06 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 25.90 | 96,850 | 2,508,415 | 1,315,605 | 1.4 M to 1.3 M (-6.86 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 168,000 | 0 | 1,412,455 | 1.2 M to 1.4 M (+13.50 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 170,000 | 0 | 1,244,455 | 1.1 M to 1.2 M (+15.82 %) |
| Aug 22 2019 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 21.51 | 8,678 | 186,664 | 1,083,133 | 1.1 M to 1.1 M (-0.79 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 135.65 | 726 | 98,482 | 4,424 | 5.2 K to 4.4 K (-14.10 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,920 | 0 | 5,150 | 3.2 K to 5.2 K (+59.44 %) |
| May 22 2019 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 19.84 | 8,678 | 172,172 | 1,091,811 | 1.1 M to 1.1 M (-0.79 %) |
| Feb 22 2019 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 27.00 | 13,477 | 363,879 | 1,099,462 | 1.1 M to 1.1 M (-1.21 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 147,000 | 0 | 1,112,939 | 965.9 K to 1.1 M (+15.22 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 170,000 | 0 | 965,939 | 795.9 K to 965.9 K (+21.36 %) |
| Nov 21 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 24.79 | 15,557 | 385,658 | 795,939 | 811.5 K to 795.9 K (-1.92 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 26.95 | 15,557 | 419,261 | 904,063 | 919.6 K to 904.1 K (-1.69 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.61 | 660 | 116,563 | 4,950 | 5.6 K to 5 K (-11.76 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.03 | 3,437 | 605,015 | 5,610 | 9 K to 5.6 K (-37.99 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.31 | 3,542 | 624,481 | 9,047 | 12.6 K to 9 K (-28.14 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,495 | 0 | 12,589 | 11.1 K to 12.6 K (+13.48 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.15 | 9,000 | 1,585,341 | 11,094 | 20.1 K to 11.1 K (-44.79 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Buy | M | 46.83 | 4,500 | 210,735 | 20,094 | 15.6 K to 20.1 K (+28.86 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,594 | 11.1 K to 15.6 K (+40.56 %) |
| Jun 25 2018 | OMED | OncoMed Pharmaceut ... | Winningham Rick E | Director | Option Exercise | A | 2.55 | 15,000 | 38,250 | 15,000 | |
| May 22 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 24.31 | 67,617 | 1,643,769 | 919,620 | 987.2 K to 919.6 K (-6.85 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 105,000 | 0 | 987,237 | 882.2 K to 987.2 K (+11.90 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 29.09 | 13,005 | 378,315 | 881,372 | 894.4 K to 881.4 K (-1.45 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 894,377 | 866.4 K to 894.4 K (+3.23 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 144.22 | 3 | 433 | 11,094 | 11.1 K to 11.1 K (-0.03 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 142.36 | 659 | 93,815 | 11,097 | 11.8 K to 11.1 K (-5.61 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,365 | 0 | 11,756 | 10.4 K to 11.8 K (+13.14 %) |
| Aug 11 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 24.50 | 10,000 | 245,000 | 866,377 | 856.4 K to 866.4 K (+1.17 %) |
| Jun 02 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 150.00 | 5,000 | 750,000 | 10,391 | 15.4 K to 10.4 K (-32.49 %) |
| Jun 02 2017 | OMED | OncoMed Pharmaceut ... | Winningham Rick E | Director | Option Exercise | A | 3.30 | 15,000 | 49,500 | 15,000 | |
| May 23 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 36.83 | 15,460 | 569,392 | 856,377 | 871.8 K to 856.4 K (-1.77 %) |
| Feb 22 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 33.78 | 33,264 | 1,123,658 | 870,135 | 903.4 K to 870.1 K (-3.68 %) |
| Feb 08 2017 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 903,399 | 875.4 K to 903.4 K (+3.20 %) |
| Nov 22 2016 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 31.96 | 8,360 | 267,186 | 875,399 | 883.8 K to 875.4 K (-0.95 %) |
| Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 136.45 | 633 | 86,373 | 15,391 | 16 K to 15.4 K (-3.95 %) |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,365 | 0 | 16,024 | 14.7 K to 16 K (+9.31 %) |
| Jun 24 2016 | OMED | OncoMed Pharmaceut ... | Winningham Rick E | Director | Option Exercise | A | 12.61 | 15,000 | 189,150 | 15,000 | |
| Mar 17 2016 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 280,000 | 0 | 882,056 | 602.1 K to 882.1 K (+46.51 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 12.13 | 16,860 | 204,512 | 602,056 | 585.2 K to 602.1 K (+2.88 %) |
| Aug 17 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Buy | P | 11.79 | 63,140 | 744,421 | 583,298 | 520.2 K to 583.3 K (+12.14 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 183.36 | 4 | 733 | 14,659 | 14.7 K to 14.7 K (-0.03 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 179.98 | 797 | 143,444 | 14,663 | 15.5 K to 14.7 K (-5.16 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,310 | 0 | 15,460 | 14.2 K to 15.5 K (+9.26 %) |
| Jun 26 2015 | OMED | OncoMed Pharmaceut ... | Winningham Rick E | Director | Option Exercise | A | 24.60 | 30,000 | 738,000 | 0 | |
| Feb 24 2015 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 19.52 | 1,480 | 28,890 | 520,158 | 521.6 K to 520.2 K (-0.28 %) |
| Jun 04 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 46,200 | 0 | 859,238 | 813 K to 859.2 K (+5.68 %) |
| Jun 04 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 110,000 | 0 | 813,038 | 703 K to 813 K (+15.65 %) |
| May 12 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 26.86 | 50,225 | 1,349,044 | 703,038 | 753.3 K to 703 K (-6.67 %) |
| Apr 29 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 82,500 | 0 | 753,263 | 670.8 K to 753.3 K (+12.30 %) |
| Feb 24 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 39.98 | 9,297 | 371,694 | 670,763 | 680.1 K to 670.8 K (-1.37 %) |
| Nov 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 36.40 | 10,046 | 365,674 | 680,060 | 690.1 K to 680.1 K (-1.46 %) |
| Sep 13 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 40.03 | 22,353 | 894,791 | 690,106 | 712.5 K to 690.1 K (-3.14 %) |
| Aug 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 35.89 | 10,046 | 360,551 | 712,459 | 722.5 K to 712.5 K (-1.39 %) |
| Jul 26 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 722,505 | 711.5 K to 722.5 K (+1.55 %) |
| May 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 37.01 | 10,046 | 371,802 | 711,505 | 721.6 K to 711.5 K (-1.39 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 9.69 | 385,161 | 3,731,247 | 0 | |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 34.32 | 1,577 | 54,123 | 721,551 | 723.1 K to 721.6 K (-0.22 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 33.64 | 253,955 | 8,543,046 | 723,128 | 977.1 K to 723.1 K (-25.99 %) |
| May 02 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 9.69 | 385,161 | 3,731,247 | 977,083 | 591.9 K to 977.1 K (+65.07 %) |
| Feb 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 22.10 | 10,655 | 235,476 | 591,922 | 602.6 K to 591.9 K (-1.77 %) |
| Feb 11 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 602,577 | 591.6 K to 602.6 K (+1.86 %) |
| Oct 17 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 591,577 | 580.6 K to 591.6 K (+1.89 %) |
| Aug 22 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 27.01 | 10,681 | 288,494 | 580,577 | 591.3 K to 580.6 K (-1.81 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 64,516 | 200,000 | 0 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 80,645 | 250,000 | 0 | |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 28.15 | 36,200 | 1,019,030 | 591,258 | 627.5 K to 591.3 K (-5.77 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 27.77 | 39,549 | 1,098,276 | 627,458 | 667 K to 627.5 K (-5.93 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 64,516 | 200,000 | 667,007 | 602.5 K to 667 K (+10.71 %) |
| Aug 07 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 80,645 | 250,000 | 602,491 | 521.8 K to 602.5 K (+15.45 %) |
| May 22 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 20.33 | 10,681 | 217,145 | 521,846 | 532.5 K to 521.8 K (-2.01 %) |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 9.69 | 30,967 | 300,070 | 0 | |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 3.10 | 32,258 | 100,000 | 0 | |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 9.69 | 30,967 | 300,070 | 532,527 | 501.6 K to 532.5 K (+6.17 %) |
| May 04 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 3.10 | 32,258 | 100,000 | 501,560 | 469.3 K to 501.6 K (+6.87 %) |
| Feb 22 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 18.54 | 21,386 | 396,496 | 469,302 | 490.7 K to 469.3 K (-4.36 %) |
| Feb 17 2012 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 11,000 | 0 | 490,688 | 479.7 K to 490.7 K (+2.29 %) |
| Nov 22 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 22.34 | 6,218 | 138,910 | 479,688 | 485.9 K to 479.7 K (-1.28 %) |
| May 12 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 26.28 | 73,100 | 1,921,068 | 485,906 | 559 K to 485.9 K (-13.08 %) |
| May 12 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 26.41 | 54,646 | 1,443,201 | 559,006 | 613.7 K to 559 K (-8.91 %) |
| Mar 03 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 22.53 | 63,873 | 1,439,059 | 613,652 | 677.5 K to 613.7 K (-9.43 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 101,752 | 867,436 | 0 | |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 135,850 | 1,158,121 | 101,752 | |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 135,950 | 1,158,974 | 237,602 | |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 23.49 | 37,200 | 873,828 | 677,525 | 714.7 K to 677.5 K (-5.20 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 22.49 | 29,800 | 670,202 | 714,725 | 744.5 K to 714.7 K (-4.00 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 101,752 | 867,436 | 744,525 | 642.8 K to 744.5 K (+15.83 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 22.74 | 42,000 | 955,080 | 642,773 | 684.8 K to 642.8 K (-6.13 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 22.22 | 50,200 | 1,115,444 | 684,773 | 735 K to 684.8 K (-6.83 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 135,850 | 1,158,121 | 734,973 | 599.1 K to 735 K (+22.67 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 21.45 | 93,100 | 1,996,995 | 599,123 | 692.2 K to 599.1 K (-13.45 %) |
| Feb 28 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 135,950 | 1,158,974 | 692,223 | 556.3 K to 692.2 K (+24.44 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 142,500 | 1,214,813 | 373,552 | |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 246,411 | 2,100,654 | 516,052 | |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | M | 8.53 | 11,729 | 99,990 | 0 | |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 21.14 | 97,600 | 2,063,264 | 556,273 | 653.9 K to 556.3 K (-14.93 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 142,500 | 1,214,813 | 653,873 | 511.4 K to 653.9 K (+27.87 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 22.15 | 10,300 | 228,145 | 511,373 | 521.7 K to 511.4 K (-1.97 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Sell | S | 21.43 | 158,500 | 3,396,655 | 521,673 | 680.2 K to 521.7 K (-23.30 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 246,411 | 2,100,654 | 680,173 | 433.8 K to 680.2 K (+56.81 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | M | 8.53 | 11,729 | 99,990 | 433,762 | 422 K to 433.8 K (+2.78 %) |
| Feb 23 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 22.50 | 6,790 | 152,775 | 422,033 | 428.8 K to 422 K (-1.58 %) |
| Feb 15 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 220,000 | 0 | 428,823 | 208.8 K to 428.8 K (+105.35 %) |
| Feb 15 2011 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 27,500 | 0 | 208,823 | 181.3 K to 208.8 K (+15.17 %) |
| Nov 23 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 22.52 | 5,555 | 125,099 | 181,323 | 186.9 K to 181.3 K (-2.97 %) |
| Oct 28 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 27,500 | 0 | 186,878 | 159.4 K to 186.9 K (+17.25 %) |
| Aug 23 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 14.00 | 3,624 | 50,736 | 159,378 | 163 K to 159.4 K (-2.22 %) |
| May 21 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 13.02 | 3,625 | 47,198 | 163,002 | 166.6 K to 163 K (-2.18 %) |
| Feb 23 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 10.22 | 2,413 | 24,661 | 166,627 | 169 K to 166.6 K (-1.43 %) |
| Feb 12 2010 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 55,000 | 0 | 169,040 | 114 K to 169 K (+48.23 %) |
| Nov 24 2009 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 14.04 | 2,364 | 33,191 | 114,040 | 116.4 K to 114 K (-2.03 %) |
| Aug 21 2009 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 15.65 | 2,303 | 36,042 | 116,404 | 118.7 K to 116.4 K (-1.94 %) |
| May 22 2009 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 14.06 | 2,303 | 32,380 | 118,707 | 121 K to 118.7 K (-1.90 %) |
| Mar 24 2009 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 80,000 | 0 | 121,010 | 41 K to 121 K (+195.07 %) |
| Feb 24 2009 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 14.87 | 2,108 | 31,346 | 41,010 | 43.1 K to 41 K (-4.89 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.50 | 11,457 | 120,299 | 43,118 | 31.7 K to 43.1 K (+36.19 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.49 | 200 | 2,098 | 31,661 | 31.5 K to 31.7 K (+0.64 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.46 | 3,600 | 37,656 | 31,461 | 27.9 K to 31.5 K (+12.92 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.44 | 500 | 5,220 | 27,861 | 27.4 K to 27.9 K (+1.83 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.43 | 100 | 1,043 | 27,361 | 27.3 K to 27.4 K (+0.37 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.42 | 414 | 4,314 | 27,261 | 26.8 K to 27.3 K (+1.54 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.41 | 1,000 | 10,410 | 26,847 | 25.8 K to 26.8 K (+3.87 %) |
| Mar 11 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Buy | P | 10.40 | 2,729 | 28,382 | 25,847 | 23.1 K to 25.8 K (+11.80 %) |
| Jan 31 2008 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 23,118 | 0 | 23,118 | 0 to 23.1 K |
| Apr 27 2007 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | A | 34.00 | 69,355 | 2,358,070 | 69,355 | |
| Feb 10 2006 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Option Exercise | A | 29.65 | 69,355 | 2,056,376 | 69,355 |
Page: 1